Junli Xue
Junli Xue has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Fanxianzi Meng
Central Laboratory, The Second Affiliated Hospital of Shandong First Medical University
2 shared publicationsBoyan Liu
Key Laboratory of Major Diseases and Hydrogen Medical Translational Applications in Universities of Shandong Province, Taishan Institute for Hydrogen Biomedical Research, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China
1 shared publication- Boyan Liu
Central Laboratory, The Second Affiliated Hospital of Shandong First Medical University
1 shared publication Deling Yin
Key Laboratory of Major Diseases and Hydrogen Medical Translational Applications in Universities of Shandong Province, Taishan Institute for Hydrogen Biomedical Research, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China
1 shared publicationGeru Tao
Key Laboratory of Major Diseases and Hydrogen Medical Translational Applications in Universities of Shandong Province, Taishan Institute for Hydrogen Biomedical Research, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China
1 shared publicationHui Pei
Key Laboratory of Major Diseases and Hydrogen Medical Translational Applications in Universities of Shandong Province, Taishan Institute for Hydrogen Biomedical Research, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China
1 shared publication
Latest Publications
- Open Access
- 23 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1923673
Gut microbiota as a potential mediator of the disease-ameliorating effects of molecular hydrogen: mechanisms and therapeutic perspectives
Molecular hydrogen (H 2 ) has emerged as a promising bioactive gas with well-documented antioxidant, anti-inflammatory, and cytoprotective properties, and its therapeutic potential for a range of human diseases has been increasingly recognized. Accumulating evidence suggests that the gut microbiota (GM) may contribute to some of the biological effects of H 2 . The GM serves as both a key site for endogenous H 2 production and consumption, and a potential site of interaction with exogenous H 2 supplementation, with possible implications for intestinal microecological homeostasis. This narrative review critically summarizes current evidence on the bidirectional relationship between H 2 and the GM, focusing on microbial H 2 production and consumption, the potential role of H 2 in maintaining gut microbial homeostasis, and the impact of exogenous H 2 supplementation on intestinal microecology. The potential therapeutic relevance of H 2 -associated GM modulation is further discussed in metabolic diseases, gastrointestinal disorders, and neurodegenerative diseases. Proposed mechanisms include regulation of microbial composition, reinforcement of intestinal barrier integrity, suppression of inflammation and oxidative stress, modulation of microbial metabolites, and gut-organ axis signaling. Collectively, current evidence supports that H 2 may influence the GM ecosystem. However, most supporting data remains preclinical, and whether GM alterations causally mediate the biological or therapeutic effects of H 2 remains to be established. Elucidating the reciprocal interaction between H 2 and the GM may provide new mechanistic insight into H 2 -based interventions and facilitate the development of microbiota-targeted therapeutic strategies for human diseases.
- 23 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1923673
Open AccessGut microbiota as a potential mediator of the disease-ameliorating effects of molecular hydrogen: mechanisms and therapeutic perspectives
Molecular hydrogen (H 2 ) has emerged as a promising bioactive gas with well-documented antioxidant, anti-inflammatory, and cytoprotective properties, and its therapeutic potential for a range of human diseases has been increasingly recognized. Accumulating evidence suggests that the gut microbiota (GM) may contribute to some of the biological effects of H 2 . The GM serves as both a key site for endogenous H 2 production and consumption, and a potential site of interaction with exogenous H 2 supplementation, with possible implications for intestinal microecological homeostasis. This narrative review critically summarizes current evidence on the bidirectional relationship between H 2 and the GM, focusing on microbial H 2 production and consumption, the potential role of H 2 in maintaining gut microbial homeostasis, and the impact of exogenous H 2 supplementation on intestinal microecology. The potential therapeutic relevance of H 2 -associated GM modulation is further discussed in metabolic diseases, gastrointestinal disorders, and neurodegenerative diseases. Proposed mechanisms include regulation of microbial composition, reinforcement of intestinal barrier integrity, suppression of inflammation and oxidative stress, modulation of microbial metabolites, and gut-organ axis signaling. Collectively, current evidence supports that H 2 may influence the GM ecosystem. However, most supporting data remains preclinical, and whether GM alterations causally mediate the biological or therapeutic effects of H 2 remains to be established. Elucidating the reciprocal interaction between H 2 and the GM may provide new mechanistic insight into H 2 -based interventions and facilitate the development of microbiota-targeted therapeutic strategies for human diseases.
- 30 April 2026
- Published by Elsevier in Life Sciences
- Vol. 397, 124418
Consumption of hydrogen-rich water ameliorates atherosclerosis by modulating gut microbiota and enhancing short-chain fatty acid levels
- 30 April 2026
- Published by Elsevier in Life Sciences
- Vol. 397, 124418
Consumption of hydrogen-rich water ameliorates atherosclerosis by modulating gut microbiota and enhancing short-chain fatty acid levels